N -acetylcysteine for major mental disorders: a systematic review and meta-analysis of randomized controlled trials

Pharmacokinetic modelling of modified acetylcysteine infusion regimens used in the treatment of paracetamol poisoning

(2017) Anselm Wong et al.   EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY

Adjunctive celecoxib for schizophrenia: A meta-analysis of randomized, double-blind, placebo-controlled trials

(2017) Wei Zheng et al.   JOURNAL OF PSYCHIATRIC RESEARCH

Oxidative stress reduction related to the efficacy of n-3 polyunsaturated fatty acids in first episode schizophrenia: Secondary outcome analysis of the OFFER randomized trial

(2017) T. Pawełczyk et al.   PROSTAGLANDINS LEUKOTRIENES AND ESSENTIAL FATTY ACIDS

Prevalence, incidence and mortality from cardiovascular disease in patients with pooled and specific severe mental illness: a large-scale meta-analysis of 3,211,768 patients and 113,383,368 controls

(2017) Christoph U. Correll et al.   World Psychiatry

Cardiometabolic comorbidities, readmission, and costs in schizophrenia and bipolar disorder: a real-world analysis

(2017) Christoph U. Correll et al.   Annals of General Psychiatry

An assessment of the variation in the concentration of acetylcysteine in infusions for the treatment of paracetamol overdose

(2016) George P. Bailey et al.   BRITISH JOURNAL OF CLINICAL PHARMACOLOGY

N-Acetylcysteine in Depressive Symptoms and Functionality

(2016) Brisa S. Fernandes et al.   JOURNAL OF CLINICAL PSYCHIATRY

A meta-analysis of blood cytokine network alterations in psychiatric patients: comparisons between schizophrenia, bipolar disorder and depression

(2016) D R Goldsmith et al.   MOLECULAR PSYCHIATRY

N-acetylcysteine for therapy-resistant tobacco use disorder: a pilot study

(2015) Eduardo Prado et al.   REDOX REPORT

N-Acetyl Cysteine in the Treatment of Obsessive Compulsive and Related Disorders: A Systematic Review

(2015) Georgina Oliver et al.   Clinical Psychopharmacology and Neuroscience

A Meta-Analysis of Oxidative Stress Markers in Depression

(2015) Tao Liu et al.   PLoS One

The Efficacy of AdjunctiveN-Acetylcysteine in Major Depressive Disorder

(2014) Michael Berk et al.   JOURNAL OF CLINICAL PSYCHIATRY

N-acetylcysteine in psychiatry: current therapeutic evidence and potential mechanisms of action

(2014) Olivia Dean et al.   JOURNAL OF PSYCHIATRY & NEUROSCIENCE

Risks of all-cause and suicide mortality in mental disorders: a meta-review

(2014) Edward Chesney et al.   World Psychiatry

Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement

(2013) David Moher   ANNALS OF INTERNAL MEDICINE

Meta-Analysis of Oxidative Stress in Schizophrenia

(2013) Joshua Flatow et al.   BIOLOGICAL PSYCHIATRY

N-Acetylcysteine as an Adjunct to Risperidone for Treatment of Negative Symptoms in Patients With Chronic Schizophrenia

(2013) Mehdi Farokhnia et al.   CLINICAL NEUROPHARMACOLOGY

N-Acetylcysteine Augmentation to Tranylcypromine in Treatment-Resistant Major Depression

(2013) André F. Carvalho et al.   JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY

Global burden of disease attributable to mental and substance use disorders: findings from the Global Burden of Disease Study 2010

(2013) Harvey A Whiteford et al.   LANCET

The promise of N-acetylcysteine in neuropsychiatry

(2013) Michael Berk et al.   TRENDS IN PHARMACOLOGICAL SCIENCES

N-acetylcysteine improves redox status, mitochondrial dysfunction, mucin-depleted crypts and epithelial hyperplasia in dextran sulfate sodium-induced oxidative colitis in mice

(2012) Ilhem Amrouche-Mekkioui et al.   EUROPEAN JOURNAL OF PHARMACOLOGY

The relevance of oxidative stress status in first episode and recurrent depression

(2012) Cristinel Stefanescu et al.   JOURNAL OF AFFECTIVE DISORDERS

The Psychiatric Manifestations of Mitochondrial Disorders

(2012) Rebecca E. Anglin et al.   JOURNAL OF CLINICAL PSYCHIATRY

Anti-inflammatory properties of N-acetylcysteine on lipopolysaccharide-activated macrophages

(2011) J. R. Palacio et al.   INFLAMMATION RESEARCH

The efficacy of N-acetylcysteine as an adjunctive treatment in bipolar depression: An open label trial

(2011) Michael Berk et al.   JOURNAL OF AFFECTIVE DISORDERS

GRADE guidelines: 3. Rating the quality of evidence

(2011) Howard Balshem et al.   JOURNAL OF CLINICAL EPIDEMIOLOGY

N-acetyl Cysteine Treatment Rescues Cognitive Deficits Induced by Mitochondrial Dysfunction in G72/G30 Transgenic Mice

(2011) David-Marian Otte et al.   NEUROPSYCHOPHARMACOLOGY

N-Acetylcysteine, a Glutamate Modulator, in the Treatment of Trichotillomania

(2009) Jon E. Grant et al.   ARCHIVES OF GENERAL PSYCHIATRY

Increased oxidative stress in the anterior cingulate cortex of subjects with bipolar disorder and schizophrenia

(2009) Jun-Feng Wang et al.   BIPOLAR DISORDERS

Reactive oxygen species-induced cell death of rat primary astrocytes through mitochondria-mediated mechanism

(2009) Chia-Chun Wang et al.   JOURNAL OF CELLULAR BIOCHEMISTRY

Total antioxidant capacity and total oxidant status in patients with major depression: Impact of antidepressant treatment

(2009) Birgul Elbozan Cumurcu et al.   PSYCHIATRY AND CLINICAL NEUROSCIENCES

Beneficial effects ofN-acetylcysteine in treatment resistant schizophrenia

(2009) Mahmut Bulut et al.   WORLD JOURNAL OF BIOLOGICAL PSYCHIATRY

Oxidation of Plasma Cysteine/Cystine Redox State in Endotoxin-Induced Lung Injury

(2008) Smita S. Iyer et al.   AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY

N-Acetyl Cysteine for Depressive Symptoms in Bipolar Disorder—A Double-Blind Randomized Placebo-Controlled Trial

(2008) Michael Berk et al.   BIOLOGICAL PSYCHIATRY

N-Acetyl Cysteine as a Glutathione Precursor for Schizophrenia—A Double-Blind, Randomized, Placebo-Controlled Trial

(2008) Michael Berk et al.   BIOLOGICAL PSYCHIATRY

Elevated serum superoxide dismutase and thiobarbituric acid reactive substances in different phases of bipolar disorder and in schizophrenia

(2008) Maurício Kunz et al.   PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY